Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
collaboration
Biotech
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
Novo Nordisk agreed to pay NanoVation up to $600 million to collaborate on programs built on technology for targeting cells outside the liver.
Nick Paul Taylor
Sep 18, 2024 9:03am
Absci inks AI R&D collab with Memorial Sloan Kettering
Aug 12, 2024 2:00pm
GSK and Genomics collab on genetics in clinical trial design
Apr 30, 2024 3:20pm
Gilead dives deeper into Nurix protein degrader collab
Apr 2, 2024 9:10am
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
Mar 15, 2024 3:10pm
Merck bets up to $1B on Pearl's 'smart' biologics
Mar 12, 2024 8:00am